Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | CureVac N.V. CVAC |
RA Capital Management, L.P. | 2,744,270 1.200% |
-9,501,685 (-77.59%) |
Filing History |
| 2024-02-06 5:10 pm Purchase |
2023-12-31 | 13G | CureVac N.V. CVAC |
GLAXOSMITHKLINE PLC | 16,591,937 7.400% |
1,656,216 (+11.09%) |
Filing History |
| 2023-03-27 5:00 pm Purchase |
2023-03-15 | 13G | CureVac N.V. CVAC |
RA Capital Management, L.P. | 12,245,955 5.500% |
12,245,955 (New Position) |
Filing History |
| 2023-02-24 4:36 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
Hothum Mathias | 70,280,385 31.700% |
-661,651 (-0.93%) |
Filing History |
| 2023-02-24 4:35 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
von Bohlen und Halback Friedrich | 469,764 0.200% |
-30,180 (-6.04%) |
Filing History |
| 2023-02-24 4:33 pm Sale |
2022-02-23 | 13D | CureVac N.V. CVAC |
Hettich Christof | 302,268 0.100% |
-716,967 (-70.34%) |
Filing History |
| 2023-02-24 4:31 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 83,880,935 37.800% |
-664,772 (-0.79%) |
Filing History |
| 2023-02-24 2:35 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
KfW | 114,190,046 51.440% |
-1,411,919 (-1.22%) |
Filing History |
| 2023-02-13 11:41 am Unchanged |
2023-02-10 | 13D | CureVac N.V. CVAC |
KfW | 115,601,965 52.080% |
0 (Unchanged) |
Filing History |
| 2022-11-14 4:02 pm Sale |
2022-11-08 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 84,545,707 45.200% |
-1,614,683 (-1.87%) |
Filing History |
| 2022-11-14 4:02 pm Sale |
2022-11-08 | 13D | CureVac N.V. CVAC |
Hothum Mathias | 70,942,036 37.900% |
-12,021,465 (-14.49%) |
Filing History |
| 2022-11-14 4:02 pm Unchanged |
2022-11-08 | 13D | CureVac N.V. CVAC |
von Bohlen und Halback Friedrich | 499,944 0.300% |
0 (Unchanged) |
Filing History |
| 2022-11-14 4:01 pm Unchanged |
2022-11-08 | 13D | CureVac N.V. CVAC |
Hettich Christof | 1,019,235 0.500% |
0 (Unchanged) |
Filing History |
| 2022-06-24 4:01 pm Sale |
2022-06-13 | 13D | CureVac N.V. CVAC |
Hettich Christof | 1,019,235 0.500% |
-81,944,266 (-98.77%) |
Filing History |
| 2022-06-24 4:01 pm Sale |
2022-06-13 | 13D | CureVac N.V. CVAC |
von Bohlen und Halback Friedrich | 499,944 0.300% |
-82,463,557 (-99.40%) |
Filing History |
| 2022-05-05 4:01 pm Purchase |
2022-05-04 | 13D | CureVac N.V. CVAC |
Hothum Mathias | 82,963,501 44.300% |
82,963,501 (New Position) |
Filing History |
| 2022-05-05 4:01 pm Purchase |
2022-05-04 | 13D | CureVac N.V. CVAC |
von Bohlen und Halback Friedrich | 82,963,501 44.300% |
82,963,501 (New Position) |
Filing History |
| 2022-05-05 4:01 pm Purchase |
2022-05-04 | 13D | CureVac N.V. CVAC |
Hettich Christof | 82,963,501 44.300% |
82,963,501 (New Position) |
Filing History |
| 2022-05-05 4:01 pm Sale |
2022-05-04 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,160,390 46.000% |
-158,700 (-0.18%) |
Filing History |
| 2022-03-17 5:10 pm Purchase |
2022-03-17 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,319,090 46.200% |
396,349 (+0.46%) |
Filing History |